Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
477 COM902 (Anti-TIGIT antibody) monotherapy – preliminary evaluation of safety, tolerability, pharmacokinetics and receptor occupancy in patients with advanced solid tumors (NCT04354246)
Compose a Response to This Article
Other responses
No responses have been published for this article.